Parabolan, the trade name for trenbolone hexahydrobenzylcarbonate, emerged as a distinctly French innovation in anabolic steroid development. Created by Negma, this compound was favored for its long-acting ester, which made it suitable for clinical use. Introduced after the research of Roussel-UCLAF, Parabolan stood apart for its anabolic potency without estrogenic side effects. Used medically to treat cachexia and bone loss, it remained on the French market until its voluntary withdrawal in 1997, after which no approved human trenbolone drugs remained.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For detailed information about Parabolan 100 AMPULES by Genetic Pharmaceuticals, consult with your doctor or healthcare professional.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.